Literature DB >> 25736016

Recurrent micronucleation through cell cycle progression in the presence of microtubule inhibitors.

Yuji Nakayama1, Narumi Uno, Katsuhiro Uno, Yamato Mizoguchi, Shinya Komoto, Yasuhiro Kazuki, Eiji Nanba, Toshiaki Inoue, Mitsuo Oshimura.   

Abstract

Although most cell lines undergo mitotic arrest after prolonged exposure to microtubule inhibitors, some cells subsequently exit this state and become tetraploid. Among these cells, limited numbers of rodent cells are known to undergo multinucleation to generate multiple small independent nuclei, or micronuclei by prolonged colcemid treatment. Micronuclei are thought to be formed when cells shift to a pseudo G1 phase, during which the onset of chromosomal decondensation allows individual chromosomes distributed throughout the cell to serve as sites for the reassembly of nuclear membranes. To better define this process, we used long-term live cell imaging to observe micronucleation induced in mouse A9 cells by treating with the microtubule inhibitor colcemid. Our observations confirm that nuclear envelope formation occurs when mitotic-arrested cells shift to a pseudo G1 phase and adopt a tetraploid state, accompanied by chromosome decondensation. Unexpectedly, only a small number of cells containing large micronuclei were formed. We found that tetraploid micronucleated cells proceeded through an additional cell cycle, shifting to a pseudo G1 phase and forming octoploid micronucleated cells that were smaller and more numerous compared with the tetraploid micronucleated cells. Our data suggest that micronucleation occur when cells shift from mitotic arrest to a pseudo G1 phase, and demonstrate that, rather than being a single event, micronucleation is an inducible recurrent process that leads to the formation of progressively smaller and more numerous micronuclei.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736016     DOI: 10.1247/csf.14005

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  5 in total

Review 1.  Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Authors:  Narumi Uno; Satoshi Abe; Mitsuo Oshimura; Yasuhiro Kazuki
Journal:  J Hum Genet       Date:  2017-11-27       Impact factor: 3.172

Review 2.  Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes.

Authors:  Sergey A Sinenko; Sergey V Ponomartsev; Alexey N Tomilin
Journal:  Cell Mol Life Sci       Date:  2020-10-03       Impact factor: 9.261

3.  Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Authors:  Aditya Parekh; Subhayan Das; Sheetal Parida; Chandan Kanta Das; Debabrata Dutta; Sanjaya K Mallick; Pei-Hsun Wu; B N Prashanth Kumar; Rashmi Bharti; Goutam Dey; Kacoli Banerjee; Shashi Rajput; Deblina Bharadwaj; Ipsita Pal; Kaushik Kumar Dey; Yetirajam Rajesh; Bikash Chandra Jena; Angana Biswas; Payel Banik; Anjan K Pradhan; Swadesh K Das; Amit Kumar Das; Santanu Dhara; Paul B Fisher; Denis Wirtz; Gordon B Mills; Mahitosh Mandal
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

Review 4.  A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges.

Authors:  Mitsuo Oshimura; Narumi Uno; Yasuhiro Kazuki; Motonobu Katoh; Toshiaki Inoue
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

5.  Moving toward a higher efficiency of microcell-mediated chromosome transfer.

Authors:  Mikhail Liskovykh; Nicholas Co Lee; Vladimir Larionov; Natalay Kouprina
Journal:  Mol Ther Methods Clin Dev       Date:  2016-06-22       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.